Semaglutide, one of the leading injections, has been shown to help individuals lose an average of 12-15% of their body weight within a year
For those also exploring other GLP-1 treatments alongside diet modifications, our blog on Saxenda vs Ozempic breaks down the key differences to help you and your doctor find the right fit
Typically, patients of our weight loss program in Austin, Texas who start FDA-approved GLP-1 medications like Ozempic and Wegovy lose an average 15% of their weight when combined with diet and exercise
Coverage for weight management alone is more limited and varies widely
Its research value comes from a simple, testable idea: combining incretin and glucagon pathway agonism in one molecule may produce measurable differences in weight reduction and metabolic markers compared with single or dual pathway approaches
Tirzepatide takes it a step further It activates both GLP-1 and GIP receptors, GIP being a second gut hormone that, when stimulated alongside GLP-1, appears to have a compounding effect on appetite suppression and fat metabolism
